MK0752
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0752, covering 2015-10-14 to 2015-10-14. Get the full timeline:
Most recent: Clinical Trial Update: MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 1]